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Mite and Cockroach Allergens Activate Protease-
Activated Receptor 2 and Delay Epidermal
Permeability Barrier Recovery
Se Kyoo Jeong1,2, Hyun Jeong Kim3, Jong-Kyung Youm1,2, Sung Ku Ahn4, Eung Ho Choi4, Myung Hyun Sohn5,
Kyu-Earn Kim5, Jeong Hee Hong6, Dong Min Shin6 and Seung Hun Lee3
Protease-activated receptor-2 (PAR-2) is known to be involved in epidermal permeability barrier function
homeostasis. PAR-2 activation occurs after barrier disruption and further activation of PAR-2 by activating
peptide significantly delays barrier recovery rate. Cockroach and house dust mite allergens, both known to be
associated with the development of asthma, allergic rhinitis, and atopic dermatitis, have protease activity, which
can activate PAR-2. In this study, we investigated the effects of both allergens on the epidermal barrier function
as well as on the epidermal calcium gradient. Both allergens, when topically applied on the barrier-disrupted
site, increased protease activities in the epidermis and delayed barrier recovery and lamellar body secretion in
murine skin. The topical application of PAR-2-specific antagonist or protease inhibitors normalized the barrier
recovery. Cockroach allergens induced intracellular calcium oscillations in cultured human keratinocytes
through PAR-2-involved pathway, which was confirmed by desensitization protocol. Abnormal calcium ion
distribution after barrier disruption was also observed in allergens-applied skin. These results suggest that
allergens with protease activity can influence the epidermal permeability barrier homeostasis through PAR-2
activation and consequent modulation of the calcium ions in skin.
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INTRODUCTION
Since the first cellular localization of protease-activated
receptor-2 (PAR-2) in human keratinocytes in vitro (Santulli
et al., 1995) and later observations of PAR-2 expression in the
basal, spinous, and granular layer of the epidermis by
immunohistochemical techniques (D’Andrea et al., 1998),
much effort has been invested to elucidate the function of
PAR-2 in skin. Human skin expresses various proteases under
both physiological and inflammatory conditions (Sharlow
et al., 2000), and these proteases are associated with various
homeostatic responses in skin disease, such as inflammation,
immune responses, host defense, chemotaxis, cytokine
expression, vascular function, tissue repair, and apoptosis
(Rattenholl and Steinhoff, 2003). Among these various
cellular responses, some might be, in part, mediated through
activation of PAR-2. For example, inflammatory mediators,
such as tumor necrosis factor-a, IL-1a, and lipopolysaccha-
ride, upregulate PAR-2 expression in endothelial cells
(Nystedt et al., 1996), and activation of PAR-2 leads to the
release of prostanoids and cytokines, including IL-6 and IL-8
in epithelial cells (Holzhausen et al., 2005). Recent studies
have also revealed the importance of PAR-2 in itching and
pain sensation. In sensory afferent nerves, PAR-2 was shown
to be associated with long-lasting thermal and mechanical
hyperalgesia in the soma as well as in visceral organs
(Vergnolle et al., 2001).
House dust mite (HDM), Dermatophagoides pteronyssi-
nus, allergens are the most frequently encountered aeroaller-
gens in temperate climates, and many studies have
implicated mite allergens in allergic diseases such as asthma
and perennial rhinitis. In skin, mite allergens may be an
exacerbating factor for atopic dermatitis (AD), an inflamma-
tory, chronically relapsing, and extremely pruritic skin
disease (Darsow et al., 2004). Recently, several studies have
reported that mite allergens have proteolytic activities and,
specifically, that the major allergens Der p3 and Der p9 from
mite allergens have protease activities. Previous studies have
also shown that both the Der p3 and Der p9 allergens can
activate PAR-2 in lung epithelial cells (Sun et al., 2001).
In addition, Der p1, the cysteine protease from the mite
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allergens, was shown to activate PAR-2 in respiratory
epithelial cells (Asokananthan et al., 2002). Cockroach
allergens are another type of major aeroallergens that can
also stimulate PAR-2 expressed in mouse lung fibroblasts
(Kondo et al., 2004) and in human airway epithelial cells
(Hong et al., 2004).
The epidermal permeability barrier function, which
controls the transcutaneous movement of water and
electrolytes, is essential to terrestrial life (Lee et al., 2006).
Disturbance of the epidermal barrier results in increased
penetration of microbes and allergens, which increases the
risk of sensitization to allergenic molecules and nonaller-
genic inflammatory reactions. It is well known that the skin
barrier function is damaged in AD patients both in acute
eczematous lesions and in clinically unaffected skin (Cork
et al., 2006). When the permeability barrier is disrupted,
finely regulated homeostatic responses are initiated to restore
the normal barrier function. Briefly, immediate secretion of
preformed lamellar bodies (LBs) into the stratum granulo-
sum–stratum corneum (SG–SC) interface occurs, followed by
a rapid formation of LBs in the upper SG. Increases in
epidermal cytokines and DNA synthesis are also induced in
homeostatic reactions (Elias, 2005). Recently, Hachem et al.
(2006) reported that topical application of PAR-2 activator
peptides on barrier-disrupted skin significantly delayed the
barrier recovery rate and interfered with the aforementioned
homeostatic responses. As the mite allergens or cockroach
allergens also have PAR-2-activating effects, the topical
application of either kind of allergens on barrier-disrupted
skin can also result in a delayed barrier recovery. To address
this issue, experimental disruption of barrier function using
repeated tape stripping on hairless mice or human volunteers
was performed, and the barrier recovery rate was measured.
In addition, to confirm whether the effects of allergens on
barrier function are due to the proteolytic activity of the
allergens and consequent activation of PAR-2, the effect of
protease inhibitor and PAR-2-specific antagonist was also
evaluated.
RESULTS
Topical application of allergens significantly delayed epidermal
permeability barrier recovery in both human and murine skin
To assess the effects of mite allergens on epidermal
permeability barrier homeostasis, human volunteers without
any skin disease and having no history of atopy were
adopted. The permeability barrier of the volar forearm was
acutely disrupted by repeated tape stripping and mite
allergens were topically applied to the barrier-disrupted skin
site. At 3 hours after barrier disruption, the barrier recovery
rate for the mite allergens-applied skin showed a significant
decrease compared to the vehicle-treated skin. At 6 hours,
mite allergens-applied skin showed a slightly lower recovery
rate than vehicle-applied skin, but statistical significance was
not observed (Figure 1a).
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Figure 1. Effects of allergens on epidermal permeability barrier. Topical application of mite allergens on barrier-disrupted skin significantly delayed
barrier recovery in human skin (a). The retardation of barrier recovery was also observed when mite allergens (b) or cockroach allergens (c) were
applied to murine skin. Repeated tape stripping was performed on both flanks of hairless mice and the barrier function was evaluated by measuring the
transepidermal water loss (TEWL) value using Tewameter TM210 (Courage and Khazaka). The preparation of both HDM allergens and GCA is explained
in Materials and Methods, and the protein concentration was 3.0 and 2.84mgml1, respectively for mite allergens and cockroach allergens. Data represent
means±SEM (n¼6, *Po0.05, **Po0.01).
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The inhibitory effect of mite allergens on epidermal
permeability barrier recovery was also observed in murine
skin. At 3 hours after barrier disruption, barrier recovery for
the mite allergens-applied site was significantly delayed
compared to the vehicle-treated site (Figure 1b). The
application of cockroach allergens also significantly delayed
barrier recovery at 3 and 6 hours (Figure 1c). The neutral
lipids distribution after barrier disruption, visualized by Nile
red staining, also showed delayed recovery of lipids in the SC
for the cockroach allergen-applied skin site, compared with
the vehicle-applied site at 3 and 6 hours after disruption
(Figure 2). To verify that the inhibitory effect of allergens
on barrier recovery is due to the activation of PAR-2 in
epidermis, PAR-2-specific inhibitor, ENMD-1,068, was
synthesized and applied to the barrier-disrupted skin site
(Kelso et al, 2006). Single application of 10mM of PAR-2
inhibitor resulted in a significant acceleration of barrier
recovery rate at 3 hours after barrier disruption, compared
with either cockroach-only application or both inhibitor and
cockroach application. However, co-application of 10mM of
PAR-2-specific antagonist with cockroach allergens did not
statistically accelerate the barrier recovery rate, possibly due
to its low antagonistic activity (Figure 3a). When higher
concentration of PAR-2 antagonist (100mM) was used,
however, barrier recovery rate was significantly increased at
3 and 6 hours after barrier disruption (Figure 3b), which
suggested an involvement of PAR-2 activation in cockroach
allergen-induced barrier impairment.
To clarify whether the decrease of SC intercellular lipids in
cockroach extract-applied skin was due to the change in LB
secretion, we examined the LB secretion system using
quantitative electron microscopy. Although there were no
significant differences in the number of protruded LBs at the
SC–SG interface between control skin and cockroach aller-
gens-applied skin immediately after barrier disruption, a
statistically significant decrease of LB protrusion was ob-
served in the cockroach allergen-applied site at 3 hours after
barrier disruption (Figure 4a). However, the synthesis of LBs
in the upper SG, represented by the number of LBs in the
cytosol of the upper SG, showed no changes after the
cockroach allergen application (Figure 4b). The above results
suggest that the retardation of barrier recovery in cockroach
extract-applied skin is, in part, due to the decreased secretion
of LBs after barrier disruption.
Topical application of cockroach allergens increased
proteolytic activities in epidermis in vivo
To clarify whether topical application of cockroach allergens
increased the proteolytic activities in vivo, protease activity in
the epidermis was examined using in situ zymography. An
increase in proteolytic activity was observed in the supraba-
sal layer after acute barrier disruption (Figure 5b), compared
with control skin (Figure 5a). These results are consistent with
previous observations of an increase in proteolytic activity in
the epidermis after barrier disruption (Hachem et al, 2006).
In addition, the topical application of cockroach allergens
after barrier disruption significantly increased the protease
activity through the whole epidermis (Figure 5c), which
suggested that increased proteolytic activity is a possible
mediator for delayed barrier recovery. Co-application of
the protease inhibitor RWJ-50,353 blocked the change
in protease activity after cockroach allergens application
(Figure 5d).
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Figure 2. Topical application of cockroach allergens on barrier-disrupted
skin caused decreased neutral lipid deposition in the stratum corneum. Nile
red staining (original magnification 200).
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Figure 3. Effects of the PAR-2-specific antagonist ENMD-1,068 on barrier
recovery. Topical application of 10mM PAR-2 antagonist significantly
accelerated barrier recovery rate after acute disruption, compared to
cockroach allergen-applied skin site (a). Although 10mM antagonist did not
reverse the barrier retardation induced by cockroach allergens, 100mM
antagonist significantly accelerated barrier recovery rate (b). Data represent
means±SEM (n46, *Po0.05, **Po0.01).
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Co-application of protease inhibitors with allergens normalized
barrier recovery
To investigate whether the inhibitory effect of both allergens
on barrier recovery were due to their proteolytic effects, the
proteolytic activities were measured using a fluorescence-
tagged substrate for protease. A proteolytic activity was
observed for both allergens, and the cockroach allergens
showed much higher activity than the HDM allergens. The
proteolytic activity was significantly reduced in the presence
of the protease inhibitor RWJ-50,353 (Seiberg et al., 2000),
which confirmed that the activities were primarily due to the
protease activities in both allergens (Figure 6a). When
the protease inhibitor RWJ-50,353 was co-applied with
cockroach extracts on barrier-disrupted skin, the recovery
rate was significantly accelerated, compared to the extracts
only-applied site (Figure 6b). The Nile red staining also
showed an increase of neutral lipid deposition at the
protease-inhibitor applied site (data not shown).
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Figure 4. Topical application of cockroach allergens delayed Lamellar body
(LB) secretion after acute barrier disruption. At 3 hours after barrier
disruption, the number of protruded LBs at the SG–SC junction significantly
decreased in cockroach allergen-applied skin compared to vehicle-treated
skin (a). The number of LBs in the upper SG, which represents the LB synthesis
after barrier disruption, did not show any significant changes after cockroach
allergen application (b). LB number was measured by counting the number of
LBs in the cytosol of keratinocyte in the upper granular layer, and the number
of protruded LBs was counted as the fused LBs in SG–SC junction. The number
of LBs in defined area of data represents means±SEM (n47, **Po0.05).
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Figure 5. Topical application of cockroach allergens increases epidermal
proteolytic activity in barrier-disrupted skin. Acute barrier disruption was
performed in hairless mice skin and protease activity was observed by in situ
zymography. Compared to the basal protease activity (a), significantly
increased protease activity was observed in barrier-disrupted skin (b). Topical
application of cockroach allergens further increased protease activity (c),
which is blocked by co-application of protease inhibitor (d).
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Figure 6. Protease activity of mite allergens and cockroach allergens.
Protease activity of mite allergens and cockroach allergens was measured by
using an EnzChek Protease Assay Kit (Molecular Probes Inc.) according to the
manufacturer’s protocol, with slight modification. Protein concentrations of
mite and cockroach allergens were 3 and 2.84mgml1, respectively, and the
concentration of protease inhibitor RWJ-50,353 (Merck Bioscience) was
5mgml1. The data represent the averaged result of triplicate experiments (a).
Topical application of protease inhibitor significantly accelerated the barrier
recovery rate of GCE-applied skin, whereas single application of protease
inhibitor did not (b). Data represent means±SEM (n46, *Po0.05).
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Cockroach extracts induced [Ca2þ ]i oscillations in cultured
human keratinocytes
In a previous study, we observed that cockroach allergens
induced a baseline type of [Ca2þ ]i oscillation in a dose-
dependent manner in human airway epithelial cells (Hong
et al., 2004). The [Ca2þ ]i oscillations induced by cockroach
allergens were due to the activation of PAR-2 in epithelial
cells, which was verified by desensitization protocols. In
cultured human keratinocytes, which also express PAR-2,
similar results were obtained and treatment with cockroach
allergens induced [Ca2þ ]i oscillations. The frequency of
the oscillations was dependent on the concentration of
cockroach allergens, but the amplitude of the spikes was
unaffected by the cockroach allergens concentration, a result
similar to that in our previous report (Hong et al., 2004)
(Figure 7a and b). Figure 7c shows that 0.5mM soybean
trypsin inhibitor reversibly inhibited the response to cock-
roach allergens. To verify whether PAR-2 activation is
involved in [Ca2þ ]i oscillations caused by cockroach
allergens treatment, we used desensitization protocols. After
desensitizing the cockroach allergen-responsive receptors by
repeated simulation with high concentrated cockroach
allergens, they showed no response to PAR-2-specific
activator peptides. However, no effect on the Ca2þ signal
evoked by sphingosine-1-phosphate, which is a different
subclass of G-protein-coupled receptor activator, was
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Figure 7. PAR-2 activation induced by cockroach allergens. [Ca2þ ]i oscillation induced by various concentrations of cockroach allergens ranging from
1 to 10 mgml1 (a) shows that the frequency of the oscillation is dose-dependently increased (b). Soybean tryptic inhibitor reversibly inhibits the calcium
responses (c), and desensitization protocol confirms that these calcium responses are elicited through PAR-2 signaling (d).
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observed in cockroach allergen-desensitized cells (Figure 7d).
These results suggest that PAR-2 is involved in cockroach
allergen-induced [Ca2þ ]i oscillation in keratinocytes.
Topical application of cockroach allergens on barrier-disrupted
skin alters the epidermal calcium gradient
Several reports suggested a close relationship between
activation of G-protein-coupled receptors and epidermal
permeability barrier homeostasis through the modulation of
intracellular calcium concentration (Ashida et al., 2001;
Denda et al., 2004). As PAR-2 belongs to a family of
G-protein-coupled seven-transmembrane domain receptors,
we postulated that the inhibitory effects of cockroach
allergens on barrier recovery may be due to the change in
intracellular calcium concentration. Using calcium-ion cap-
ture cytochemical staining, we observed changes in the
epidermal calcium gradient after barrier disruption by
electron microscopy. In normal tissue, a well-defined
epidermal calcium gradient was seen with low levels of
calcium ions in basal and spinous layers and increased
depositions in the granular layer (Figure 8a). Immediately
after barrier disruption, nearly complete loss of the calcium
gradient was observed (Figure 8b). In cockroach allergens-
applied skin, however, increased deposition of calcium ions
in granular layers was observed at 3 hours after barrier
disruption (Figure 8c), compared to the vehicle-treated skin
(Figure 8d). Co-application of PAR2-specific antagonist with
cockroach allergens prevented the increased deposition of
calcium ions in granular layer, which suggests that the
inhibitory effects of cockroach extract on barrier recovery
were possibly due to the modulation of intracellular calcium
ions in granular layers, at least partly through PAR2
activation.
DISCUSSION
The results of this study suggest that mite allergens or
cockroach allergens can be aggravating factors for epidermal
permeability homeostasis of barrier function-perturbed skin.
AD is an inflammatory, chronically relapsing, and extremely
pruritic skin disease. Whether HDM allergens or cockroach
allergens have a direct pathophysiologic role in AD remains
controversial (Beltrani and Hanifin, 2002), but a lot of studies
suggest that mite allergen sensitization is more common in
patients with AD than in non-atopic controls (Ingordo et al.,
2002; Beltrani, 2003; Goon et al., 2005). In addition to
immunologic disturbance, another characteristic feature of
AD skin lesions is the perturbation of epidermal permeability
barrier function. In normal skin, aeroallergens do not easily
reach antigen-presenting cells, such as dendritic cells in
subepithelial tissues, owing to the effective barrier function of
SC. A defective permeability barrier in AD skin lesions,
however, leads to an increased penetration of environmental
allergens into skin, which initiates immunologic reactions.
Recently, two common loss-of-function mutations in the gene
encoding filaggrin have been reported (Palmer et al., 2006;
Smith et al., 2006). As the filaggrin protein has a crucial
function in maintaining the epidermal barrier function, these
results suggest an important role of the skin barrier in
preventing allergic sensitization (Weidinger et al., 2006).
Interestingly, several reports have suggested that mite
allergens could also interfere with the epidermal barrier
function (Gfesser et al., 1996). Even in normal skin, the
simultaneous application of mite allergens with SDS induced
a highly pronounced increase in transepidermal water loss
(TEWL), compared to mite allergens- or SDS-only applied
skin (Loffler et al., 2003). As the application of SDS results in
the disruption of skin barrier function (Ahn et al., 2001), these
results suggest that mite allergens can be an aggravating
factor for epidermal permeability barrier function for com-
promised skin, an idea consistent with our results. When
barrier-disrupted skin is exposed to mite allergens, the barrier
function is perturbed further. Consequently, additional
allergens can more easily penetrate the skin, perpetuate
barrier disruption, and result in continuous eczematous
lesions in AD.
Blocking the proteolytic activities of allergens using a
protease inhibitor resulted in normalized barrier recovery,
which suggests that proteolytic activity primarily mediates the
inhibitory effects of allergens on barrier function. Activation
of PAR-2, by either endogenous or exogenous protease,
a b c d e
Figure 8. Calcium ion distribution in epidermis after barrier disruption was observed by calcium-ion capture cytochemical staining. Control skin
showed a normal epidermal calcium gradient across the epidermis (a), and nearly complete loss of the epidermal calcium gradient was observed after
acute barrier disruption (b). Increased deposition of calcium ions in granular layers was observed in cockroach allergens-applied skin (c), compared with
vehicle-treated site, at 3 hours after disruption (d). Co-application of 10mM of PAR-2-specific antagonist partially prevented the increased deposition of
calcium ions in the granular layer at 3 hours after barrier disruption (e). Bar¼ 2 mm.
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results in diverse cellular responses, including cell prolifera-
tion, differentiation, and production and release of
proinflammatory cytokines. An increase in intracellular
calcium ion concentration, through the generation of IP3
and diacylglycerol, is also induced by PAR-2 activation
(Kanke et al., 2005). It is well known that in normal
epidermis, calcium ion distribution is uneven and that this
epidermal calcium gradient plays a critical role in barrier
function homeostasis. The loss of calcium gradient after
barrier disruption induces the secretion and synthesis of LBs
in the epidermis. However, previous studies have shown that
the calcium ion influx into the granulocyte after barrier
disruption retarded the normal barrier LB secretion and
barrier repair processes (Lee et al., 1992). Activation of PAR-2
by cockroach allergens resulted in an increase in intracellular
calcium concentration in cultured human keratinocytes, and
the inhibitory effects of these allergens on skin barrier
function is due in part to this modulation of calcium ion
concentration. Calcium-ion capture cytochemical staining
showed increased calcium ion deposition in the granular
layer after barrier disruption in allergens-applied skin, which
confirmed this hypothesis.
Our results suggest that, along with the allergenic effects of
mite allergens and cockroach allergens, the proteolytic
activities of both allergens can also affect permeability barrier
homeostasis. Diverse proteolytic enzymes, such as kallikrein
(KLK) 7 (SC chymotryptic enzyme, SCCE) and KLK 5 (SC
tryptic enzyme, SCTE), and protease inhibitors, such as LEKTI
(lymphoepithelial Kazal-type-related inhibitor), exist in nor-
mal SC, and the balance between degradation and protection
of corneodesmosome proteins determines the desquamation
process. Previous reports, however, also suggested an
involvement of the KLK proteases in the pathogenesis of
inflammatory skin diseases such as AD. Increased expressions
of KLK mRNA and proteins were observed in AD skin lesions
(Komatsu et al., 2005), and using a transgenic mouse model,
it was also shown that increased KLK 7 activity in suprabasal
keratinocyte induced pathologic skin changes such as
increased epidermal skin thickness, hyperkeratosis, dermal
inflammation, and severe pruritis (Hansson et al., 2002). The
importance of increased protease activity in AD skin lesions
is also supported by the observation that protease inhibitor
expression is lowered in AD skin. The serine protease
inhibitor LEKTI is a potent inhibitor of both KLK 5 and KLK
7 (Egelrud et al., 2005), and a defect in the serine protease
inhibitor Kazal-type 5 (SPINK5) gene, encoding LEKTI, has
been reported in AD patients (Kato et al., 2003; Folster-Holst
et al., 2005). These results support the hypothesis that
increased protease activity is an important pathophysiologic
factor for inflammatory skin disease. In addition, Denda et al.
(1997) reported that the topical application of the protease
inhibitor trans-4-(aminomethyl)cyclohexane carboxylic acid
(t-AMCHA) to barrier-disrupted skin accelerated barrier
recovery in murine and human skin. A progressive degrada-
tion of epithelial tight junction proteins by the protease
activities in mite allergens was also reported previously (Wan
et al., 1999, 2001). In addition, a recent report by Nakamura
et al. (2006) suggested that the proteolytic activity of mite
allergens can result in a disruption of permeability barrier
functions. Although it needs to be investigated whether HDM
or cockroach allergens can also degrade corneodesmosome
or lipid-processing enzymes in SC, these studies suggest that
both allergens can induce abnormalities in the epidermal
permeability barrier functions, even in normal skin.
In conclusion, PAR-2 expressed in epidermal keratinocyte
has a crucial function in epidermal permeability barrier
homeostasis and the activation of PAR-2 by aeroallergens
results in a significant delay in barrier recovery. The
inhibitory effects of aeroallergens could be overcome by
the co-application of either PAR-2-specific antagonist or
protease (Figure 9). As the perturbation in epidermal
permeability barrier function is one of the most important
pathophysiologic factors in AD, our results suggest that
aeroallergens not only induce the allergic reactions but also
interfere with the barrier homeostatic responses in AD skin
lesions.
MATERIALS AND METHODS
Materials
House dust mite extracts and German cockroach extracts were
prepared according to a protocol reported previously (Jeong et al.,
2004). Briefly, 30 g of frozen dust mites and German cockroaches
were pulverized in liquid nitrogen, and the defatted samples in
200ml of a 1:1 volume of ethyl ether/ethyl acetate were extracted
with slow stirring at 4 1C overnight in a 100mM phosphate-buffered
saline solution (pH 7.4). The extracts were then centrifuged at
10,000 g for 30minutes at 4 1C and the supernatants were finally
filtered through a 0.22 mm filter. The endotoxin contents, determined
by using E-Toxate assay, were negative for both extracts. The total
protein quantity in both extracts, as evaluated by Bradford assay
reagent (Bio-Rad, Hercules, CA), measured 2.89 and 3.0mgml1,
respectively, for cockroach extract and HDM extract. The protease
inhibitor RWJ-50,353 was purchased from Merck KgaA (Darmstadt,
Germany). Trypsin type IX-S, the reference protease, was purchased
from Sigma Co. (St Louis, MO), and the protease activity of both
allergens was measured using an EnzChek Protease Assay Kit
(Molecular Probes Inc., Eugene, OR) according to the supplier’s
recommendation. The total reaction volume for the assay was 200ml
and pH-insensitive green fluorescent BODIPY-FL-conjugated casein
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Figure 9. Possible involvement of mite allergens and cockroach allergens in
epidermal permeability barrier homeostasis.
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was used as a substrate. BODIPY-FL-conjugated casein solution
(10 mgml1) was prepared with 10mM Tris-HCl buffer solution
(pH7.8) containing 0.1mM sodium azide. Preparation and dilution of
the enzyme solution or allergen extracts were performed with
phosphate-buffered saline solution (pH 7.4). In a 96-well plate
(OptiPlate 96F; Perkin Elmer, Boston, MA), 100 ml of substrate
solution and 100ml of enzyme solution or allergen extracts were
added to each well. The reaction mixture was incubated for 1 hour at
37 1C and protected from light. The fluorescence was measured by
the HTS Multilabel Reader (Perkin Elmer, Boston, MA) with an
excitation wavelength of 485 nm and an emission wavelength of
530 nm. All other chemicals used were of analytical grade.
Human studies
Five healthy male subjects (ages 27–35 years) and one healthy
female subject (age 29 years) without any history of atopy or
dermatological disease volunteered for this study. All of the subjects
registered negative in the dust mite patch test and participated in this
study after providing written informed consent. The study was
approved by the institutional review board of Yonsei University
College of Medicine and conducted according to the Declaration of
Helsinki Principles. After resting for at least 30minutes in a
temperature- (22±2 1C) and humidity (40–50%)-controlled room,
basal TEWL was measured at the volar forearm using Tewameter
TM210 (Courage and Khazaka GmbH, Cologne, Germany), and
acute disruption of the epidermal permeability barrier was
performed by repeated tape stripping using 3M cellophane tape
until the TEWL value reached about 3540 gm2 hour1. After
barrier disruption, 150ml of HDM extract was applied to the barrier-
disrupted site for 10minutes. At 3 and 6hours after barrier
disruption, TEWL was measured and the barrier recovery rate was
calculated. Phosphate-buffered saline solution (pH 7.4), which
was used for preparing dust mite and cockroach extract allergens,
was also topically applied to the barrier-disrupted skin site as a
control group.
Animals
Female hairless mice Hr/Hr were purchased from the animal
laboratory of Yonsei University and used at 8–12 weeks of age. All
animals were kept under controlled humidity (40–50%) and
temperature (22 1C) and were fed a standard diet and water ad
libitum. The use of animals was approved by the institutional review
board of Yonsei University College of Medicine. After anesthetizing
the mice using an intraperitoneal injection of 4% chloral hydrate,
basal TEWL was measured at both flanks, and the permeability
barrier was disrupted by repeated tape stripping. Immediately after
barrier disruption, 150ml of allergens were topically applied to the
barrier-disrupted site for 10minutes. Phosphate-buffered saline
solution (pH 7.4), which was used for preparing mite and cockroach
allergens, was also topically applied to the barrier-disrupted skin site
as a control group. At 3 and 6 hours after barrier disruption, TEWL
was measured and the barrier recovery rate calculated.
In situ zymographic measurement of protease activity in the
epidermis
The proteolytic activity within the epidermis was examined by in situ
zymography. Either cockroach allergens or vehicle was topically
applied to the normal or barrier-disrupted skin site of hairless mice
and skin biopsies were taken. Frozen sections (5mm thickness) were
rinsed with washing solution (1% Tween 20 in deionized water) and
incubated at 37 1C for 1 hour with 250 ml of BODIPY-Fl-casein
(1mgml1) in deionized water (2mgml1). After incubation, the
sections were rinsed with washing solution and observed under
confocal laser microscope (Zeiss LSM 500; Carl Zeiss Microimaging
Inc., Thornwood, NY) at an excitation wavelength of 485 nm and an
emission wavelength of 530 nm.
Neutral lipid deposition in stratum corneum
Skin biopsies of hairless mice were taken at 3 and 6 hours after
barrier disruption and Nile red staining was performed to observe the
neutral lipids distribution in the SC. Nile red solution of 4mM
(100mgml1 and 75% glycerol) was applied to cryostat sections
(5mm thickness), and specimens were examined by confocal laser
scanning microscopy (Bio-Rad MRC 600 mounted on a Zeiss
LSM510 inverted microscope). Excitation and emission wavelengths
were 488 nm and 514nm, respectively. At least five sections were
observed to find common features and representative sections were
selected.
Cell culture and [Ca2þ ]i measurement
Neonatal human epidermal keratinocytes (Cascade Biologics,
Portland, OR) were grown in EpiLife Medium supplemented with
supplied growth factors (Cascade Biologics). Cells were grown at
37 1C in a humidified atmosphere of 5% CO2 and 95% air. For dye
loading, the cells were seeded on polylysine-coated coverslips at
4 106 cells per ml per 60mm dish and used at 80% confluency.
The composition of the extracellular physiologic salt solution
used for measuring the [Ca2þ ] change was as follows:
NaCl, 140mmol l1; KCl, 5mmol l1; MgCl2, 1mmol l
1; CaCl2,
1mmol l1; HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid), 10mmol/l; and glucose, 10mmol l1 titrated to pH 7.4 with
NaOH. Ca2þ -free media was Ca2þ -free physiologic salt solution
that contained 1mmol l1 EDTA and 1mmol l1 EGTA (ethylene-
glycol-bio-(b-aminoethylether)-N,N,N0,N0-tetraacetic acid). Cells
were incubated for 2 hours in physiologic salt solution containing
5mmol l1 fura-2-acetoxymethyl ester in the presence of Pluronic
F-127 to enhance dye loading. Changes in [CA2þ ]i were measured
by means of fura-2 fluorescence, with excitation wavelengths of 340
and 380nm, respectively, and an emission wavelength of 510 nm at
room temperature. Background fluorescence was subtracted from
the raw signals at each excitation wavelength before calculating the
fluorescence ratio as follows:
Ratio ¼ F340=F380
The emitted fluorescence was monitored with a charge-coupled
device camera (Photon Technology International Inc., Lawrence-
ville, NJ) attached to an inverted microscope.
Electron microscopy
After biopsy, skin samples were fixed in modified Karnovsky’s
fixative overnight, and post-fixed with 0.25% ruthenium tetroxide
containing 1.5% potassium ferrocyanide, as described previously
(Hou et al., 1991). After further counterstaining with lead citrate,
ultrathin sections (LEICA ultracut UCT, LEICA, Nussloch, Germany)
were examined under an electron microscope (Hitachi H7600,
Hitachi, Tokyo, Japan) operating at 80 kV. LB density and secretion
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were assessed visually in randomly selected photographs without
knowledge of the experimental treatment groups. The numbers of
protrusions were quantitated and accessed planimetrically as the
number per unit length of the SC–SG junction. To measure LB
numbers in the upper SG, LB images in the cytosol of the uppermost
two layers of the SG were counted and expressed as the average
number per unit area of cytosol.
Calcium-ion capture cytochemistry was performed to investigate
the change in epidermal calcium ion distribution in murine skin.
After biopsy, the specimens were finely minced and immersed in an
ice-cold fixative that contained 2% glutaraldehyde, 2% formalde-
hyde, 90mM potassium oxalate, and 1.4% sucrose (pH 7.4). After
overnight incubation, specimens were post-fixed in 1% OsO4
containing 2% potassium pyroantimonate for 2 hours. After embed-
ding in Epon-epoxy resin mixture, ultrathin sections were examined
under the electron microscope operating at 80 kV. At least
10 electron micrographs were taken for each specimen and
representative pictures were also taken.
Statistical analyses and data presentation
Statistical analyses were performed using InStat 3 software
(GraphPad Software Inc., San Diego, CA). Non-paired two-tailed
Student’s t-test was performed to calculate the statistical significance.
Values are given as means±SEM.
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